Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
Kingfa Science and Technology (India) posted sharp Q1 FY27 profit and revenue growth, with higher margins, a domestic-heavy mix, and results filed on 14 August 2026.
Sunrakshakk Industries posted 121% YoY sales growth to ₹276.33 crore and 131% YoY net profit rise to ₹15.04 crore for the June 2026 quarter.
Expleo Solutions posted double-digit Q1 FY27 revenue growth with sharper EBITDA and PAT, expanding margins and lifting net cash, while the stock traded around ₹838.
Expleo Solutions reported higher Q1 FY27 revenue and improved margins, with adjusted EBITDA and PAT rising year-on-year, while sequential operating revenue growth stayed limited.
Maxgrow India approved FY26 audited results on August 10, 2026, accepted two director resignations, and later corrected a BSE filing omission amid compliance role vacancies.
KSE Ltd’s FY26 audited results show revenue from operations of Rs 1,680.48 crore and PAT of Rs 84.04 crore, alongside a total dividend of Rs 12.50 per share.
Advik Capital reported a Q3 FY25 consolidated net loss of ₹20.87 crore, and its board later approved a ₹100 crore rights issue to strengthen capital.
Amara Raja Energy and Mobility reported Q1 FY27 consolidated revenue of INR 4,214.54 crore and net profit of INR 190.94 crore, while EBITDA margin narrowed to 9.6%.
Advik Capital’s Q3 FY26 filing showed a ₹20.87 crore loss and negative operating revenue, alongside committee changes and a proposed ₹100 crore rights issue.
Lodha Developers has set its 31st AGM for August 14, 2026 via VC, with a ₹4.25 final dividend proposal and August 7 as the record date.
Tamil Nadu Telecommunications reported a standalone net loss of ₹3.69 crore in the March 2026 quarter on zero revenue, with Q1 FY27 earnings due on 14 August 2026.
Tamil Nadu Telecommunications reported nil revenue and a Q4 FY26 net loss of ₹3.69 crore, with its next earnings scheduled for 14 August 2026.
Vaxfab Enterprises reported a -47.03% YoY drop in Q4 FY26 net profit to ₹2.14 crore, while citing ₹45.99 crore revenue and a 166.05% QoQ profit jump.
Parmax Pharma has scheduled an August 14, 2026 board meeting for June-quarter results, with trading closure for 48 hours after disclosure amid an open offer and preferential issue.
Vaxfab Enterprises reported sharp FY26 profit growth and scheduled an August 14, 2026 board meeting for Q1 FY27 unaudited results, while auditors issued a disclaimer over records.
Panorama Studios International is set to report Q1 FY26-27 results on 14 Aug 2026 after a sharp YoY drop in Q4 FY25-26 revenue and profit; stock was ₹47.50.